Sotagliflozin in Patients with Diabetes andChronic Kidney Disease – The SCORED Trial
dc.contributor.author | Riddle, Matthew C | |
dc.contributor.author | McGuire, Darren K | |
dc.contributor.author | Lewis, Julia B | |
dc.contributor.author | Inzucchi, Silvio E | |
dc.contributor.author | KUDAT, HASAN | |
dc.contributor.author | Leiter, Lawrence A | |
dc.date.accessioned | 2022-07-04T15:28:14Z | |
dc.date.available | 2022-07-04T15:28:14Z | |
dc.identifier.citation | Leiter L. A. , McGuire D. K. , Lewis J. B. , Riddle M. C. , Inzucchi S. E. , KUDAT H., "Sotagliflozin in Patients with Diabetes andChronic Kidney Disease – The SCORED Trial", American Hear Assosiation Congres, 16 Kasım 2020 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_b10b6cd1-e4c1-4205-930d-8834f8d1c63f | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/184271 | |
dc.language.iso | eng | |
dc.title | Sotagliflozin in Patients with Diabetes andChronic Kidney Disease – The SCORED Trial | |
dc.type | Bildiri | |
dc.contributor.department | , , | |
dc.contributor.firstauthorID | 3402262 |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |
This item appears in the following Collection(s)
-
Bildiri [64839]